Radiopharm Theranostics Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of September 2026 for Radiopharm Theranostics Limited, a foreign private issuer headquartered in Carlton South, Victoria, Australia. The report discloses a specific corporate governance event rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the disclosure of director interest changes and contains no financial statements or operational metrics.
Material Changes
The material change reported is the publication of four "Change of Director's Interest Notices" on the Australian Securities Exchange on September 22, 2026. No financial or operational changes versus prior periods are detailed in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The document explicitly states it is not deemed "filed" for purposes of the Securities Exchange Act of 1934 and shall not be incorporated by reference into registration statements.
Investor Verification Checklist
- Verify the specific details of the four director interest changes referenced in Exhibit 99.1.
- Confirm the identity of the directors whose interests were altered.
- Review the attached Public Notice on the Australian Securities Exchange for transaction specifics not included in this summary.